Features US fund to invest in Basel company The US investment firm Versant Ventures has launched a new fund worth USD 400 million with the aim of investing in 20 to 25 biotechnology…Jérémie Meyer13.01.2017
Features PIQUR enters into partnership to fight skin cancer The Basel-based pharmaceutical company PIQUR Therapeutics is entering into a partnership with the French pharmaceutical group Pierre Fabre to collaborate in the field of dermato-oncology.Jérémie Meyer11.01.2017